TFEB and atherosclerosis: The activation of lysosome biogenesis by TFEB overexpression suppresses cholesterol crystal-induced NLRP3 inflammasome, attenuating the progression of atherosclerosis, in vitro and in vivo (Emanuel et al., 2014).